KMT2A and leukemia: To be able to identify markers of responsiveness to SID7969543, such as the presence of certain molecular abnormalities (e.g., specific KMT2A translocations), a future larger scale screening in an expanded panel of KMT2A-r leukemia cell lines is warranted.